Veriheal

JULY 2, 2025

researchers found that longer, more punitive sentences failed to reduce self-reported illegal drug use, overdose deaths, or drug-related arrests. It is believed that only about 9% of all cannabis users will develop a marijuana addiction. These harsher penalties also did not lower recidivism rates.

Edibles 52

Edibles Research and Development Decriminalization Law 52

Veriheal

JUNE 10, 2025

Researchers have steadily advanced the field of psychedelic-assisted therapy over the last decade or two. This passage also spurred the development of an eagerly anticipated psychedelic-assisted therapy industry, now ready to see its very first patients very soon.

Therapy 59

Therapy Medicine Programs Treatment 59

Veriheal

JUNE 26, 2025

Lykos has expressed plans to request that the regulatory agency reconsider the decision and meet for a productive discussion, but no one has announced any new developments in this effort yet. Unfortunately, such large-scale clinical studies typically take years and cost millions of dollars to perform.

Clinical Trials 52

Clinical Trials Therapy Research and Development Treatment 52

Cannabis Chronicles

MAY 22, 2019

SPOKANE — Researchers at Washington State University are teaming up with the Puyallup Tribe of Indians in an effort to chart the tribe’s outcomes prescribing medicinal marijuana to patients. This partnership with WSU and Qwibil will help us research the safety and efficacy of cannabis as medicine for our patients’ use.”.

Medicine 140

Medicine Research and Development Data Collective 140

Cannabis Law Report

AUGUST 10, 2021

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Madison Natarajan, MS. – August 5, 2021.

Clinical Trials 105

Clinical Trials Research and Development Therapy Treatment 105

Cannabis Law Report

DECEMBER 27, 2019

Clinical trials are medical research projects involving human participants. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies. AI-Powered search platform maximizes access to publications. Mobile communities advance consumer research.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Americans for Safe Access

MAY 25, 2021

You will also find out how to access the recorded panels from Unity 2021 to catch anything you missed. Information on research steps from NIDA and DEA, House progress on SAFE Banking and other key bills, Developments in Alabama and Mississippi a call to action for veterans and a profile of ASA's 2021 Researcher of the Year, Philippe Lucas.

Research and Development 165

Research and Development DEA Banking Access 165

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.

Research and Development 124

Research and Development Data THC Clinical Trials 124

NORML

FEBRUARY 15, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Send a message to your lawmakers in support of medical marijuana access. AL resident? KY resident? MD resident?

Legislation 280

Legislation Decriminalization Access Patients 280

NORML

MARCH 1, 2019

Currently, the sole federally licensed producer of cannabis for clinical research is the University of Mississippi. ” The agency said that the policy change was necessary because the existing system provided “no clear legal pathway for commercial enterprises to produce marijuana for product development.”

DEA 200

DEA Research and Development Clinical Trials Marijuana 200

Cannabis Law Report

AUGUST 15, 2021

Aims to support acceleration of clinical development of low-dose psilocybin in SUNHA and 5MeO-DMT in other neuro-psychiatric indications. The progress Beckley Psytech has made in attracting exceptional talent to the team and advancing our ambitious clinical development programmes over the past two years has been tremendously exciting.

Medicine 98

Medicine Research and Development Conditions Treatment 98

Veriheal

SEPTEMBER 14, 2021

The findings of a new study into cannabis use disorder (CUD) among veterans have been released by a team of researchers from Pennsylvania’s Center of Excellence in Substance Addiction Treatment and Education at the Corporal Michael J. Crescenz VA Medical Center. Their hypothesis was published in the American Journal of Psychiatry.

Consumption 98

Consumption Research and Development Treatment Programs 98

Americans for Safe Access

MAY 21, 2019

Americans for Safe Access Wants to Help You Navigate the Federal Regulatory Process. What the FDA and other regulatory agencies look for during the commenting process are concise, well-thought-out responses that cite scientific research and make recommendations for sound public policy.

Research and Development 189

Research and Development Policy Food Programs 189

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

NORML

MARCH 7, 2019

Shanita Penny, President of the Minority Cannabis Business Association (MCBA) said , “The Ending Federal Marijuana Prohibition Act of 2019 removes a roadblock impeding criminal justice reform, patient and consumer access, research and innovation.

Legislation 250

Legislation Marijuana Policy Research and Development 250

Veriheal

JANUARY 31, 2023

The obvious reasons for choosing the illicit market over the legal market include the likes of easier accessibility and lower cost. However, Clement states that the manner in which they operate is “actually what should be the models for business development in this industry.” But what about the risks that come with illicit cannabis?

Legalization 105

Legalization Research and Development Business Cannabis 105

Cannabis Law Report

AUGUST 17, 2022

Ohio State Legal Studies Research Paper No. According to its sponsors and supporters, the Safe and Fair Enforcement (‘SAFE’) Banking Act would help address the challenges faced by small cannabis businesses that cannot currently access banking services or loans. Ohio State Legal Studies Research Paper No. Cat Packer.

Banking 98

Banking Access Research and Development Compliance 98

Cannabis Law Report

JUNE 28, 2021

Together we want to advance the development of high-quality medicinal cannabis and have made it our mission to improve the quality of life of neurological patients who still have symptoms despite conventional therapy. ” “Supporting therapies, like medical cannabis, are a meaningful addition to Zambon’s European portfolio. “As

Access 105

Access Research and Development Pharmaceutical Therapy 105

Veriheal

MARCH 17, 2022

However, new research has found that psychedelic use is only “weakly associated with psychosis-like symptoms.” New Research Published on Serotonergic Psychedelic Use and Psychosis. New Research Published on Serotonergic Psychedelic Use and Psychosis. The research team under the leadership of Alexander V.

Research and Development 98

Research and Development Therapy Conditions History 98

Cannabis Law Report

JULY 6, 2021

This collaboration is intended to include research into COMP360 psilocybin therapy and other novel therapies that may be developed by COMPASS in areas of unmet need such as depression, post-traumatic stress disorder (PTSD) and anorexia.

Research and Development 76

Research and Development Clinical Trials Therapy Patients 76

Veriheal

AUGUST 21, 2023

million in gifts in support of several causes, including the promotion of arts, Lyme and tick-borne disease research, protection of the environment, and, in this case, psychedelics research. to advance scientific research into the potential therapeutic benefits of psychedelics for mental health and well-being.

Therapy 95

Therapy Research and Development Treatment Environment 95

Project CBD

NOVEMBER 11, 2023

NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.

Medicine 309

Medicine Research and Development Pharmaceutical Cannabis 309

Cannabis Law Report

JULY 28, 2021

This direct access to patients and clinics is expected to differentiate KGK from other CROs by providing the opportunity to study patients with differing demographics across various populations, while also shortening recruitment timelines for studies.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

Cannabis Law Report

JULY 29, 2021

Scientists and researchers do not know exactly how or why these negative results occur, but they are still working on the question. The Ehave Infinity Portal offers a powerful machine learning and artificial intelligence platform with a growing set of advanced tools and applications developed by Ehave and its leading partners.

Research and Development 81

Research and Development Conditions Data Patients 81

Cannabis Law Report

SEPTEMBER 8, 2021

Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).

Access 97

Access Research and Development Medicine THC 97

Cannabis Law Report

AUGUST 30, 2021

The goal of the research is to provide a foundation for the discovery and characterization of additional sources of genetic resistance to the various pathogens that infect C. Mihalyov, PhD and Oregon CBD Director of Research & Development Andrea R. Authors included Dewey Scientific Co-Founder Paul D. Garfinkel, PhD.

Research and Development 79

Research and Development Sativa Agriculture Cultivation 79

Project CBD

JULY 28, 2023

From 1994 to 2013, he was employed as a principal investigator at DuPont Central Research and Development. End cannabis prohibition, the market for these products will go away and these compounds will be relegated to research labs, where they belong, not the marketplace. with unknown pharmacological and safety profiles.”

THC 220

THC Cannabinoids Hemp Research and Development 220

Cannabis Law Report

SEPTEMBER 10, 2021

The announcement of a partnership between Clerkenwell Health and Octarine Bio signals a momentous time for the growth and development of the European psychedelic ecosystem. Clerkenwell Health is a psychedelic specialist clinical research organisation, based in the UK, backed with investment from VC Fund Vine Ventures, and Angel investors.

Research and Development 104

Research and Development Clinical Trials Therapy Environment 104

Cannabis Law Report

JULY 16, 2021

The group’s primary focus is to provide the necessary resources and guidance to advance a comprehensive medical cannabis package that allows professionalization, clinical research and greater access. The Council represents ACCM’s further commitment to support legislation that allows research and access.

Legislation 98

Legislation Medicine Research and Development Advocacy 98

Cannabis Law Report

JULY 19, 2021

We don’t want to see research fall to the wayside as it has for cannabis, both in Canada and globally. LMC Manna Research is also part of hyperCORE International, which has access to more than 100 award winning research sites across two continents making them the second largest clinical research site organization globally.

Clinical Trials 75

Clinical Trials Research and Development Hybrid Medicine 75

NORML

APRIL 4, 2019

Our outdated laws have ruined lives, devastated communities, and wasted resources for critical medical treatment and research. They have stimulated economic development and created hundreds of millions of dollars in new tax revenue. It’s time for Congress to catch up with the rest of America are and fix a badly broken system.”

Policy 194

Policy Business Research and Development Marijuana 194

NORML

JANUARY 4, 2019

Steve Cohen (D-TN) and Don Young (R-AK) re-introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act, which protects those engaged in state-lawful medical marijuana programs from federal prosecution. Legislation is pending, HB 350, to expand medical cannabis access. NH resident? GA resident?

Legislation 127

Legislation Clinical Trials Research and Development Access 127

NORML

APRIL 5, 2019

Update : SB 34 was approved by the Senate Business, Professions and Economic Development Committee on 4/3/19. Legislation is pending, Senate Bill 305, to permit qualified patients the ability to access medical cannabis preparations while in health care facilities. Click here to email your lawmakers in support of banking access.

Legislation 206

Legislation Banking Hemp Compliance 206

Veriheal

DECEMBER 9, 2021

Opponents are likely referencing studies that link mental illness to regular cannabis use, even though those studies have been invalidated by research and do not even revolve around legalization. We found that recreational marijuana access was associated with a 6.29 Support From Other Studies. Singer et al.

Legalization 98

Legalization Research and Development Consumption Recreational 98

The Cannigma

JUNE 29, 2021

Though the distinction between these terms may seem trivial at first glance, it is in fact crucial for cannabis research, and therefore also for consumers and regulators as well. Researchers conducting survey based studies today often only have access to the THC concentration of the cannabis that their participants are using.

Terpenes 138

Terpenes Research and Development Cannabinoids Concentrates 138

Cannabis Law Report

JUNE 5, 2021

On Wednesday, Argentina’s Minister of Productive Development, Matías Kulfas , presented a bill titled, “Regulatory framework for the development of the medical cannabis and hemp industry ,” within the framework of the Economic and Social Council. Supplier development: Genetics, agro 4.0, Yahoo Finance reports.

Hemp 105

Hemp Research and Development Pharmaceutical Agriculture 105

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104